Education
The AE Alliance is excited to partner with the University Hospitals Neurological Institute, Hashimoto’s Encephalopathy/SREAT & Seronegative Autoimmune Encephalitis Alliance (HESA) and Encephalitis411 to present and in-person AE Day: “Strides in Autoimmune Encephalitis.” This assembly is an all-day event focusing on pediatric and adult autoimmune encephalitis (AE) for clinicians, caregivers, and the survivors impacted. We […]
We are excited to announce Stanley J. Naides, MD, FACP, FACR, Chair, Board of Directors, Autoimmune Encephalitis Alliance as our speaker for the September 2024 AEA Provider Monthly Didactic + Case Discussion series, The Role of the Laboratory in Autoimmune Neurology. The identification of pathological autoantibodies to neural targets has aided diagnosis and prognosis in patients […]
Many thanks to Dr. Jerome Graber for the August 2024 session of our AEA Provider Monthly Education Series, “Paraneoplastic” neurologic disorders: A case-based review. The session included general principles of diagnosis and treatment for paraneoplastic and autoimmune neurologic disorders and their mimics. NOTE: Case presentation & discussion occurs throughout the presentation and is edited out. The edits […]
Many thanks to Dr. Sarosh Irani for kicking off our new AEA Provider Monthly Didactic + Case Discussion Series with a presentation on LGI1 Antibody Encephalitis. The AEA Monthly Didactic + Case Discussion series benefits greatly from the invaluable contributions of our committed autoimmune encephalitis experts. These professionals volunteer their precious time, sharing their profound wisdom […]
The AE Alliance and Medical Advisory Board (MAB) are excited to announce our new AEA Monthly Didactic + Case Discussion series. The AE Alliance hosted its inaugural Challenging Case Conference in February 2023. Every alternating month, the MAB and Clinicians Network members were invited to deliberate on challenging cases and explore innovative diagnostic and treatment […]
A recently published study is providing a close look at anti-LGI1 encephalitis which, after anti-NMDA receptor encephalitis, is the second most common autoimmune encephalitis. Anti-LGI1 encephalitis most often affects middle aged patients who come to medical attention because of the quick onset (over a few weeks to a few months) of memory loss. Less commonly […]
Making the diagnosis of autoimmune encephalitis (AE) can be very straightforward when the patient develops features that are highly characteristic of a particular AE. For example, a 30-year old woman with new onset psychiatric symptoms such as hallucinations or strange behaviors and who also has repetitive movements around their mouth in their face (known as […]
We were recently asked to post and comment on the proposed pediatric autoimmune encephalitis (AE) classification criteria published in 2020. The pediatric criteria followed much of the framework of the adult criteria, but highlighted important difference between pediatric and adult presentations. In addition, the pediatric criteria started from the point of the initial assessment, with […]
AE Alliance is proud to be joining forces with The Anti-NMDA Receptor Encephalitis Foundation, Encephalitis 411, the Encephalitis Society, HESA, and Encephalitis Global in organizing the World Encephalitis Day 2020 Conference in Dallas, TX. The World Encephalitis Day 2020 Conference welcomes survivors and caregivers to attend and interact while celebrating World Encephalitis Day. We feel very fortunate to have […]
Dr. Soon-Tae Lee received an AEA Community Seed Grant in 2021. Today, in honor of Research Network Month, he provides an update on his research with seronegative autoimmune encephalitis: clinical characteristics and courses, the effect of immunotherapy and its duration, and prognostic factors. The AEA Community Seed Grant program is funded by donations from the […]